Are You Looking for a Top Momentum Pick? Why Context Therapeutics Inc. (CNTX) is a Great Choice [Yahoo! Finance]
Context Therapeutics Inc. (NASDAQ: CNTX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $4.50 price target on the stock.
Context Therapeutics Inc. (NASDAQ: CNTX) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $4.50 price target on the stock.
Context Therapeutics Inc. (CNTX) Upgraded to Buy: Here's Why [Yahoo! Finance]
Context Therapeutics Inc. (NASDAQ: CNTX) had its price target raised by analysts at HC Wainwright from $4.00 to $5.00. They now have a "buy" rating on the stock.